Dr. Jordan M. Maier, MD

Dr. Maier practices at Karmanos Cancer Center in Detroit, Michigan, part of McLaren Health Care.

Dr. Maier's NPI, 1578515490, was assigned on May 17, 2006. Dr. Maier graduated from Wayne State University School Of Medicine in 2001. Dr. Maier holds Michigan license 4301077896.

Dr. Maier's primary practice is Karmanos Cancer Center, at 4100 John R, Detroit, MI 48201 in Wayne County. The practice phone is (800) 576-6266.

Dr. Maier's primary practice is Karmanos Cancer Center in Detroit, Michigan, part of McLaren Health Care. The medical group on file is Wayne Health. Dmand AI also links Dr. Maier to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maier practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Maier's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Maier is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Maier's licenses on file in 2 states: Michigan and Florida.

Dmand AI lists bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and pancreatic cancer radiation among the conditions Dr. Maier treats.

CMS data shows 880 Medicare services from Dr. Maier across 12 procedure codes in 2024, for 80 Medicare patients. Medicare paid $57,276 for them.

CMS counts 80 Medicare patients who saw Dr. Maier in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maier's median patient age at 72, with 47% women.

In 2024, Dr. Maier wrote 151 Medicare Part D claims for 45 patients. 94% of them were for generic drugs. CMS names the drug for 84 of them, across 4 drugs with 11 or more claims each, at $44,949 in total drug cost. In 2023, CMS named 51 claims across 2 drugs.

Dr. Maier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maier as offering telehealth.

Dmand AI links 10 papers to Dr. Maier, published from 2012 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms. Dr. Maier has published most often in Int J Radiat Oncol Biol Phys. Dr. Maier's most frequent co-authors are Jason A. Efstathiou, MD, Jeff Michael Michalski, MD and Thomas M. Pisansky, MD.

Dmand AI links Dr. Maier to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Adenocarcinoma, Bronchiolo-Alveolar, Breast Neoplasms and Adenocarcinoma of Lung. Barbara Ann Karmanos Cancer Institute sponsors the most, 3.

CMS Open Payments shows 1 general payment to Dr. Maier from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $18.

Dr. Maier graduated from Wayne State University School Of Medicine in 2001.

Dr. Maier is in network with 18 carriers, including Aetna, Elevance and Health Alliance Plan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.